Nanosonics Limited
NNCSFOTCHealthcare● Active
$2.07
+$0.00(+0.00%)
Market Cap$618556218
P/E Ratio—
52W High$3.0575
52W Low$2.01
Nanosonics Limited（NNCSF）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · NNCSF · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-06 | 2024-06 | 2023-06 | 2022-06 | 2021-06 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $0.00B | $0.00B | $0.02B | $0.00B | $0.01B |
| Depreciation & Amort. | $0.00B | $0.00B | $0.01B | $0.01B | $0.00B |
| Stock-Based Comp. | $0.00B | $0.00B | $0.01B | $0.00B | $0.00B |
| Change in Working Capital | $0.00B | ($0.00B) | ($0.01B) | $0.00B | ($0.01B) |
| Net Cash from Operations | $0.04B | $0.02B | $0.02B | $0.01B | $0.01B |
| Investing Activities | |||||
| Capital Expenditure | ($0.01B) | ($0.00B) | ($0.00B) | ($0.01B) | ($0.00B) |
| Purchases of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Sales of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Investing | ($0.01B) | ($0.00B) | ($0.00B) | ($0.01B) | ($0.00B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | $0.00B | $0.00B | ($0.00B) | ($0.00B) | ($0.00B) |
| Net Cash from Financing | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Free Cash Flow | |||||
| Free Cash Flow | $0.04B | $0.02B | $0.02B | ($0.00B) | $0.01B |
| FCF Margin %(computed) | 17.72% | 11.92% | 11.79% | -0.23% | 5.76% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · AUD · B
深入了解Nanosonics Limited
关于Nanosonics Limited（NNCSF）现金流量表
Nanosonics Limited 2025财年经营活动现金流$0.04B，自由现金流$0.04B（FCF利润率17.72%），资本支出($0.01B)。
常见问题
NNCSF · 4 问Nanosonics Limited 2025财年自由现金流$0.04B，同比up74.0%。
NNCSF free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10